Literature DB >> 24085758

Commentary on "The risky business of studying prognosis".

Anna Broder1, Chaim Putterman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24085758      PMCID： PMC3904680          DOI： 10.3899/jrheum.130393

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  8 in total

1.  Systematic reviews of evaluations of prognostic variables.

Authors:  D G Altman
Journal:  BMJ       Date:  2001-07-28

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  The risky business of studying prognosis.

Authors:  Lily Siok Hoon Lim; Brian M Feldman
Journal:  J Rheumatol       Date:  2012-12-01       Impact factor: 4.666

4.  A review of goodness of fit statistics for use in the development of logistic regression models.

Authors:  S Lemeshow; D W Hosmer
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

5.  Real world experience with antiphospholipid antibody tests: how stable are results over time?

Authors:  D Erkan; W J M Derksen; V Kaplan; L Sammaritano; S S Pierangeli; R Roubey; M D Lockshin
Journal:  Ann Rheum Dis       Date:  2005-02-24       Impact factor: 19.103

6.  The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus.

Authors:  Hyejung Jung; Raja Bobba; Jiandong Su; Zhaleh Shariati-Sarabi; Dafna D Gladman; Murray Urowitz; Wendy Lou; Paul R Fortin
Journal:  Arthritis Rheum       Date:  2010-03

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus.

Authors:  Anna Broder; Chaim Putterman
Journal:  J Rheumatol       Date:  2012-08-01       Impact factor: 4.666
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.